Application
Antibody-Drug Conjugates
Revolutionizing oncology with precision targeting and potent therapeutic action
Unlocking the potential of antibody-drug conjugates
Antibody-drug conjugates (ADCs) are advanced cancer treatments designed to target cancer cells directly, sparing healthy cells. They combine the precise targeting of monoclonal antibodies with the powerful, cancer-killing capabilities of cytotoxic drugs. Unlike traditional chemotherapy, ADCs can distinguish between healthy and diseased tissue, resulting in a more effective and less harmful treatment. Manufacturing ADCs presents unique challenges, requiring specialized cleanrooms, equipment, and safety protocols to handle these potent biological drugs safely and efficiently.
Facilities and Equipment for Your Antibody-Drug Conjugates Application
Select from a number of application-ready layouts and equipment. If these do not meet your needs, reach out and learn more about our custom solutions.
Frequently Asked Questions
What are antibody-drug conjugates (ADCs)?
Antibody-drug conjugates (ADCs) are advanced cancer treatments designed to target cancer cells directly while sparing healthy cells. They combine the precise targeting of monoclonal antibodies with the powerful, cancer-killing capabilities of cytotoxic drugs.
How are ADCs different from traditional chemotherapy?
Unlike traditional chemotherapy, ADCs can distinguish between healthy and diseased tissue, resulting in a more effective and less harmful treatment.
What challenges does ADC manufacturing present?
Manufacturing ADCs presents unique challenges, requiring specialized cleanrooms, equipment, and safety protocols to handle these potent biological drugs safely and efficiently.
What facility options does Germfree offer for ADC manufacturing?
Germfree offers a bioGO® Mobile cGMP Cleanroom for urgent capacity needs and clinical-phase or point-of-care manufacturing, as well as prefabricated Modular cGMP Cleanroom facilities for longer-term production, available as free-standing facilities or installed inside a shell building.
What compliance standards do Germfree’s ADC manufacturing cleanrooms meet?
Germfree’s cleanroom platforms are built to meet FDA cGMP requirements, US and EU cGMP, BSL-2/BSL-3, ISPE Baseline Guides, and ISO 14644 classification standards, depending on configuration.
What equipment supports ADC manufacturing?
Germfree’s primary engineering controls (PECs) include Pharmaceutical Isolators, Restrictive Access Barriers, Laminar Flow Workstations, Biological Safety Cabinets (BSCs), Compounding Aseptic Isolators (CAIs), Compounding Aseptic Containment Isolators (CACIs), and Material Pass-Throughs, all built with 100% stainless steel construction.
Talk to us about the right solution for your application
Contact usWhen your mission calls for something custom, we deliver.
Some environments can’t take a catalog answer: the one-of-a-kind containment lab, the facility that has to survive shipment by military aircraft, the compounding pharmacy that has to stand up overnight. Tell us the constraints, we’ll build around them.
Related insights

Beyond the Blueprint: Practical Infrastructure for Cell Therapy Manufacturing



















